# Pemvidutide for fatty liver (MASLD): 24-week trial results

Source: https://pepvault.app/research/pemvidutide-browne-2025

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Pemvidutide](https://pepvault.app/research#pemvidutide)

Randomized trial · people

# Pemvidutide: up to 76.4% liver fat reduction at 24 weeks in MASLD

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this trial, staying on pemvidutide for 24 weeks lowered liver fat more than 12 weeks did, with the 1.8 mg and 2.4 mg arms showing the largest drops.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 64
- **Published:** 2025
- **Journal:** JHEP Rep

## What they tested

The team tested whether 12 more weeks of pemvidutide, for 24 weeks in total, would further lower liver fat and body weight in people with MASLD, a fatty liver disease linked to metabolic dysfunction.

## How the study was done

A double-blind, placebo-controlled extension of a randomized trial, in which 64 people who finished the first 12 weeks stayed on their original weekly shot of pemvidutide (1.2 mg, 1.8 mg or 2.4 mg) or placebo, a dummy shot, for 12 more weeks. Participants were stratified by type 2 diabetes, meaning those with and without it were grouped separately when assigned.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

After 24 weeks, liver fat fell from its starting level by 56.3% in the 1.2 mg arm, 75.2% in the 1.8 mg arm and 76.4% in the 2.4 mg arm, compared with 14.0% on placebo. Liver fat was measured by MRI-PDFF, an MRI scan that measures the share of the liver that is fat. In the 1.8 mg arm, 84.6% of people cut their liver fat by at least half, and 53.8% reached a normal level of 5% or less. Body weight fell by 6.2% over the 24 weeks, and side effects were uncommon at all doses.

## What it doesn’t show

Only people who completed the first 12 weeks entered this extension, and the group was small and followed for only 24 weeks. Liver fat was measured by imaging, so the study does not show effects on long-term liver outcomes.

## The paper

Browne et al. Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial. JHEP Rep. 2025.

- [PubMed (PMID 41113119)](https://pubmed.ncbi.nlm.nih.gov/41113119/)
- [The paper (DOI 10.1016/j.jhepr.2025.101483)](https://doi.org/10.1016/j.jhepr.2025.101483)
- [ClinicalTrials.gov (NCT05292911)](https://clinicaltrials.gov/study/NCT05292911)

## The compound

- [Pemvidutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)

## With this study

### Pemvidutide

- [Pemvidutide: the full reference](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pemvidutide-10mg)

### Studies

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026)
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025)
- [All 4 studies](https://pepvault.app/research#pemvidutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Pemvidutide

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026) Randomized trial · people · 2026
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025) Randomized trial · people · 2025
- [Pemvidutide cut body weight about 25% in mice with NASH](https://pepvault.app/research/pemvidutide-nestor-2022) Animal study · mice · 2022
- [Every study on Pemvidutide](https://pepvault.app/research#pemvidutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Pemvidutide

- [Pemvidutide: the full reference](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pemvidutide-10mg)

### Studies

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026)
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025)
- [All 4 studies](https://pepvault.app/research#pemvidutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Pemvidutide](https://pepvault.app/research#pemvidutide)

## The library

- [Pemvidutide](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
